Your browser doesn't support javascript.
loading
Topical concentrated epinephrine (1:1000) does not cause acute cardiovascular changes during endoscopic sinus surgery.
Gunaratne, Dakshika A; Barham, Henry P; Christensen, Jenna M; Bhatia, Daman D S; Stamm, Aldo C; Harvey, Richard J.
Afiliação
  • Gunaratne DA; Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.
  • Barham HP; Department of Otolaryngology-Head and Neck Surgery, Westmead Hospital, Sydney, Australia.
  • Christensen JM; Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.
  • Bhatia DD; Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.
  • Stamm AC; Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.
  • Harvey RJ; Department of Otolaryngology-Head and Neck Surgery, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Int Forum Allergy Rhinol ; 6(2): 135-9, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26383187
ABSTRACT

BACKGROUND:

Topical epinephrine is used in endoscopic sinonasal surgery for local vasoconstriction. Potential for cardiovascular complications remains a concern for some due to the possibility of systemic absorption. Topical vs injected epinephrine was examined in a prospective analysis of perioperative cardiovascular effects, and in an audit of cardiovascular complications during endoscopic sinonasal surgery.

METHODS:

A prospective cohort study of patients undergoing endoscopic sinonasal surgery was performed. Topical (11000) and injected (1100,000) epinephrine were assessed. Cardiovascular outcomes of heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and electrocardiogram (ECG) changes were examined at baseline and minutely post-topical application (to 10 minutes) and postinjection (to 5 minutes). A retrospective assessment of cardiovascular events associated with a standardized regimen of topical (12000) and injected (1100,000) epinephrine was performed.

RESULTS:

Nineteen patents were assessed (43.42 ± 15.90 years, 47.4% female) in the prospective analysis. Post-topical epinephrine, no significant changes occurred in any cardiovascular parameter. However, following injected epinephrine, changes in HR (59.53 vs 64.11 bpm, p < 0.001), SBP (96.16 vs 102.95 mmHg, p = 0.015), DBP (56.53 vs 60.74 mmHg, p = 0.019), and MAP (69.74 vs 74.81 mmHg, p = 0.002) occurred. On repeated-measures analysis of variance (ANOVA) all parameters were significantly affected by injection. No ECG abnormalities were seen in either topical or injection phases. The retrospective analysis of 1260 cases identified 2 cases of cardiovascular complications (0.16%), both relating to injected epinephrine.

CONCLUSION:

Combination topical (11000 to 12000) and injectable (1100,000) epinephrine is safe for use in endoscopic sinonasal surgery. Injection resulted in the cardiovascular changes and accounted for the cardiovascular events reported.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Seios Paranasais / Doenças Cardiovasculares / Epinefrina / Hemorragia Pós-Operatória / Endoscopia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int Forum Allergy Rhinol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Seios Paranasais / Doenças Cardiovasculares / Epinefrina / Hemorragia Pós-Operatória / Endoscopia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int Forum Allergy Rhinol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália